In the present study, we found that CD4+CD25+FoxP3+ (Treg) and CD4+FoxP3+PD-1+ (PD-1+Treg) cells were enriched in BM microenvironment of patients with AML and exhibited a stronger inhibitory ability against effector T cells. This evidence concerns the gene CD4 and acute myeloid leukemia.